AMH and ovarian hyperstimulation syndrome: Whereas, a small but clinically substantial proportion of women with high ovarian reserve may be stratified to receive a higher gonadotrophin dose based on the Access AMH assay, with an inherent increased risk of iatrogenic ovarian hyperstimulation syndrome or cycle cancellation (Steward et al., 2014).